The Magnetic Resonance Imaging Coils Market revenues were estimated at US$ 8.5 Billion in 2022 and are anticipated to grow at a CAGR of 8.3% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach a valuation of US$ 20.3 Billion. …
Category Archives: Healthcare Trends
UK in Specialty Medical Chairs Market is projected to expand at a CAGR of around 8.9% from 2023 to 2033
The Specialty Medical Chairs Market revenues were estimated at US$ 3 Billion in 2022 and are anticipated to grow at a CAGR of 8.7% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 7.5 Billion. The revenue from the US market …
Increasing Incidence of Burn Injuries to Propel the Growth of for Burn Treatment Market at 6% CAGR through 2033: FMI Study
The global Burns Treatment Market is expected to garner a market value of US$ 1.2 Billion in 2023 and is expected to accumulate a market value of US$ 2.59 Billion by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Burns Treatment registered a CAGR of 5% in the …
Surgical Drapes Market is projected to reach US$ 2.1 Billion by 2033 at a CAGR of 4.2%
The Surgical Drapes Market revenues were estimated at US$ 1.4 Billion in 2022 and is anticipated to grow at a CAGR of 4.2% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 2.1 Billion. The market revenue through disposable …
Unstable Angina Therapeutics Market to expand at a CAGR of 5%, reaching a value of US$ 6.6 billion by 2033: FMI
According to a recently published Future Market Insights report, the global Unstable Angina Therapeutics Market is forecast to expand at a CAGR of 5% until 2033, reaching US$ 6.6 billion. Based on a Cleveland Clinic study, approximately 200,000 Americans suffer from unstable angina every year. Unstable angina is more prevalent among older people, men, and …
Ulcerated Ncerobiosis Lipoidica Management Market to reach US$ 7.9 billion by 2033, expected to grow at a CAGR of over 6%: FMI Study
The global Ulcerated Necrobiosis Lipoidica Management Market is anticipated to attain an impressive valuation of US$ 4.4 billion in 2023 and is projected to reach US$ 7.9 billion by 2033, trailing a CAGR of 6.03 % during the forecast period. Increasing advanced diagnostic technique for diagnosis of necrobiosis lipoidica like magnetic resonance imaging is expected …
Infertility Drugs Market is projected to reach US$ 6,814.68 Million by 2033 at a CAGR of 6.3 %
The global Infertility Drugs Market size was valued at US$ 3,699.8 million in the year 2023 and is projected to grow to US$ 6,814.68 million by 2033. This market is expected to register a CAGR of 6.3% during the analysis period. Due to the increase in infertility, a rise in the demand for infertility drugs …
Chronic Refractory Cough Treatment Market is projected to reach USD 17.1 billion by 2033, trailing a CAGR of 6.39%
The Chronic Refractory Cough Treatment Market is anticipated to be worth US$ 9.2 billion in 2023 and US$ 17.1 billion by 2033, growing at a CAGR of 6.39%. The market for treatments for refractory chronic cough is driven by the rising prevalence of refractory chronic cough worldwide. The size of the market would increase, enabling pharmaceutical companies …
Glioblastoma Treatment Drugs Market is projected to be valued at US$ 1,259.13 million by 2032
The global glioblastoma treatment drugs market is worth US$ 723.3 Mn as of now and is expected to reach US$ 1.26 Bn by the year 2032 at a CAGR of 5.7% between 2022 and 2032. Patients have started getting clinical trials with development agents. Biomarkers are more successful regarding personalized medicine. There is a likelihood of tumor …
Diamond-Blackfan Anemia (DBAAASE) Syndrome Therapeutics Market is expected to garner a value of US$ 7.29 Billion by 2033
The global Diamond-Blackfan Anemia (DBAAASE) Syndrome Therapeutics Market is predicted to exceed an impressive US$ 4.8 Billion in 2023, with a compound annual growth rate (CAGR) of 4.2% from 2023 to 2033. The global Diamond–Blackfan Anemia (DBAAASE) Syndrome Therapeutics market is expected to garner a market value of US$ 7.29 Billion by 2033. Because 90% of infected …